Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kurt Graves currently holds 64,564 shares of Seres Therapeutics, Inc. (MCRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kurt Graves has been a net seller of MCRB stock. They have purchased $100.3K and sold $5.6M worth of shares.
Kurt Graves's most recent insider trade was on Jul 1, 2024, when they sold 64,564 shares at $0.00 per share.
Kurt Graves serves as Executive at Seres Therapeutics, Inc. (MCRB). They have executed 54 insider transactions totaling $5.7M over their tenure at the company.
Kurt Graves holds the position of Executive at Seres Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kurt Graves has shown a selling trading pattern, with $100.3K in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kurt Graves was on Jul 6, 2015, when they sold $1.7M worth of RDUS shares. This transaction involved 25,000 shares at $69.48 per share.
Kurt Graves currently owns 64,564 shares of Seres Therapeutics, Inc. (MCRB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kurt Graves's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kurt Graves has 54 Form 4 filings on record as an insider at Seres Therapeutics, Inc..
Set alerts for Kurt Graves and 40,000+ other insiders.